Literature DB >> 20237491

Antigen-specific CD8 T cells can eliminate antigen-bearing keratinocytes with clonogenic potential via an IFN-gamma-dependent mechanism.

Rachel L De Kluyver1, Linnea Moritz, Craig A Harris, Hiroaki Azukizawa, Ian H Frazer.   

Abstract

The immune system surveys the skin for keratinocytes (KCs) infected by viruses or with acquired genetic damage. The mechanism by which T cells mediate KC elimination is however undefined. In this study we show that antigen-specific CD8 T cells can eliminate antigen-bearing KCs in vivo and inhibit their clonogenic potential in vitro, independently of the effector molecules perforin and Fas-ligand (Fas-L). In contrast, IFN-gamma receptor expression on KCs and T cells producing IFN-gamma are each necessary and sufficient for in vitro inhibition of KC clonogenic potential. Thus, antigen-specific cytotoxic T lymphocytes (CTLs) may mediate destruction of epithelium expressing non-self antigen by eliminating KCs with potential for self-renewal through an IFN-gamma-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20237491     DOI: 10.1038/jid.2010.49

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  IL-17 suppresses immune effector functions in human papillomavirus-associated epithelial hyperplasia.

Authors:  Christina Gosmann; Stephen R Mattarollo; Jennifer A Bridge; Ian H Frazer; Antje Blumenthal
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

2.  The kinematics of cytotoxic lymphocytes influence their ability to kill target cells.

Authors:  Purnima Bhat; Graham Leggatt; Klaus I Matthaei; Ian H Frazer
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

3.  Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity.

Authors:  Purnima Bhat; Graham Leggatt; Nigel Waterhouse; Ian H Frazer
Journal:  Cell Death Dis       Date:  2017-06-01       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.